Physician profile
Gordon E Wuebbolt
NPI 1548234255
$2,690.64
in general payments reported to CMS, 2019-2025
18 companies · $293 in 2025
The $293 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $277 · 2021: $443 · 2022: $435 · 2023: $471 · 2024: $573 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $811.86 | 2022-2025 | Durysta |
| Alcon Vision LLC | $431.43 | 2019-2025 | Hydrus Microstent, Centurion, Argos |
| Regeneron Healthcare Solutions, INC. | $300.16 | 2019-2025 | Eylea Hd, Eylea |
| Allergan, INC. | $295.40 | 2019-2022 | |
| Oyster Point Pharma, INC. | $165.45 | 2022-2024 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $150.72 | 2020-2021 | |
| Aerie Pharmaceuticals, INC. | $132.30 | 2019-2021 | |
| Rayner Intraocular Lenses Limited | $87.81 | 2023-2025 | Omidria, Rayone Emv, Rayone Aspheric |
| Bausch & Lomb Americas INC. | $75.60 | 2022-2023 | Vyzulta, Envista Mx60 Iol, Lotemax Sm |
| Sight Sciences, INC. | $51.68 | 2021-2025 | Omni Surgical System |
| Horizon Therapeutics Plc | $37.62 | 2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $28.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $24.87 | 2019-2021 | |
| Biotissue Holdings INC. | $22.74 | 2022 | |
| Shire North American Group INC | $22.10 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $20.22 | 2020 | |
| Genentech USA, INC. | $20.03 | 2022 | |
| New World Medical,INC. | $12.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gordon Wuebbolt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.